TCM
Tekla Capital Management Portfolio holdings
AUM
$2.56B
1-Year Return
18.15%
This Quarter Return
+13.64%
1 Year Return
+18.15%
3 Year Return
+62.34%
5 Year Return
+140.22%
10 Year Return
+499.57%
AUM
$2.46B
AUM Growth
+$126M
(+5.4%)
Cap. Flow
-$109M
Cap. Flow
% of AUM
-4.43%
Top 10 Holdings %
Top 10 Hldgs %
40.31%
Holding
213
New
10
Increased
47
Reduced
69
Closed
17
Top Buys
| 1 |
Pfizer
PFE
|
$23.5M |
| 2 |
Merck
MRK
|
$21.2M |
| 3 |
Welltower
WELL
|
$14.9M |
| 4 |
Eli Lilly
LLY
|
$10.2M |
| 5 |
CELG
Celgene Corp
CELG
|
$8.65M |
Top Sells
| 1 |
Biogen
BIIB
|
$19.1M |
| 2 |
Johnson & Johnson
JNJ
|
$18.8M |
| 3 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
$16.3M |
| 4 |
AbbVie
ABBV
|
$13.9M |
| 5 |
Thermo Fisher Scientific
TMO
|
$13.5M |
Sector Composition
| 1 | Healthcare | 94.43% |
| 2 | Real Estate | 2.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
101
Coherus Oncology, Inc. Common Stock
CHRS
$150M
| $4.3M | 0.17% |
315,162
| – | – |
|
102
Amicus Therapeutics
FOLD
$2.46B
| $4.28M | 0.17% |
314,597
-560,707
| -64% | -$7.63M |
|
|
ENDP
103
DELISTED
Endo International plc
ENDP
| $4.27M | 0.17% |
531,570
-185,704
| -26% | -$1.49M |
|
|
DHC
104
Diversified Healthcare Trust
DHC
$995M
| $4.21M | 0.17% |
357,720
-19,500
| -5% | -$230K |
|
105
Bausch Health
BHC
$2.72B
| $4.17M | 0.17% |
168,812
-23,188
| -12% | -$573K |
|
106
Tenet Healthcare
THC
$17.3B
| $4.07M | 0.17% |
141,136
| – | – |
|
|
ALBO
107
DELISTED
Albireo Pharma, Inc. Common Stock
ALBO
| $4.03M | 0.16% |
125,000
| – | – |
|
|
PTLA
108
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
| $4.01M | 0.16% |
115,448
| – | – |
|
109
Ligand Pharmaceuticals
LGND
$3.25B
| $3.76M | 0.15% |
47,922
+5,523
| +13% | +$433K |
|
|
VAR
110
DELISTED
Varian Medical Systems, Inc.
VAR
| $3.72M | 0.15% |
26,227
| – | – |
|
111
Takeda Pharmaceutical
TAK
$48.6B
| $3.63M | 0.15% |
+178,128
| New | +$3.63M |
|
|
WMGI
112
DELISTED
Wright Medical Group Inc
WMGI
| $3.61M | 0.15% |
114,776
-18,615
| -14% | -$585K |
|
|
EPZM
113
DELISTED
Epizyme, Inc
EPZM
| $3.59M | 0.15% |
289,404
-96,468
| -25% | -$1.2M |
|
114
argenx
ARGX
$45.9B
| $3.54M | 0.14% |
+28,381
| New | +$3.54M |
|
115
Philips
PHG
$26.5B
| $3.49M | 0.14% |
106,083
| – | – |
|
|
AERI
116
DELISTED
Aerie Pharmaceuticals, Inc.
AERI
| $3.25M | 0.13% |
68,496
+29,726
| +77% | +$1.41M |
|
117
NovoCure
NVCR
$1.37B
| $3.18M | 0.13% |
65,964
+41,464
| +169% | +$2M |
|
|
CLLS
118
Cellectis
CLLS
$269M
| $3.17M | 0.13% |
173,035
-63,495
| -27% | -$1.16M |
|
119
Acadia Pharmaceuticals
ACAD
$4.26B
| $2.81M | 0.11% |
+104,714
| New | +$2.81M |
|
120
Puma Biotechnology
PBYI
$253M
| $2.77M | 0.11% |
71,340
-12,000
| -14% | -$465K |
|
121
PTC Therapeutics
PTCT
$4.55B
| $2.58M | 0.1% |
68,652
| – | – |
|
122
Intellia Therapeutics
NTLA
$1.29B
| $2.57M | 0.1% |
150,290
| – | – |
|
123
IQVIA
IQV
$31.9B
| $2.36M | 0.1% |
16,391
-22,709
| -58% | -$3.27M |
|
|
ARNA
124
DELISTED
Arena Pharmaceuticals Inc
ARNA
| $2.34M | 0.1% |
52,262
| – | – |
|
125
Sangamo Therapeutics
SGMO
$165M
| $2.3M | 0.09% |
241,538
| – | – |
|